ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

October 29, 2010

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989

Breast-Conserving Procedures Lead To Frequent Follow-up Care

April 27, 2012

Procedures For Ending IGs Announced

July 10, 1992

Randomized Low-Fat Diet Trial To Being, Centers Sought

September 17, 1993

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976